13669-19-7

Basic information

• Product Name: 5-chloro-2-Thiopheneacetic acid
• Synonyms: 5-chloro-2-Thiopheneacetic acid
• CAS NO: 13669-19-7
• Molecular Formula: C₆H₅ClO₂S
• Molecular Weight: 176.62
• Mol File: 13669-19-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-chloro-2-Thiopheneacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloro-2-Thiopheneacetic acid(13669-19-7)
• EPA Substance Registry System: 5-chloro-2-Thiopheneacetic acid(13669-19-7)

Safety Data

• Hazardous Substances Data: 13669-19-7(Hazardous Substances Data)

Upstream product

• 71637-28-0 methyl (5-chlorothien-2-yl)acetate 
• 24065-33-6 5-Chlorothiophene-2-carboxylic acid 
• 42518-98-9 5-chlorothiophene-2-carbonyl chloride 
• 23784-96-5 2-Chloro-5-(chloromethyl)thiophene 
• 42520-90-1 (5-chlorothiophen-2-yl)acetonitrile 
• 234108-05-5 [2-(5-chlorocthiophen-2-yl)-1-dimethylaminovinyl]phosphonic acid diethyl ester 
• 1918-77-0 Thiophene-2-acetic acid 
• 7283-96-7 5-Chloro-2-thiophenecarboxaldehyde 
• 33577-16-1 methyl methylsulfinylmethyl sulfide 

Downstream Products

• 127035-88-5 4-[(E)-2-(5-Chloro-thiophen-2-yl)-vinyl]-2,6-dimethyl-phenol 
• 116376-61-5 2,6-Di-tert-butyl-4-[(E)-2-(5-chloro-thiophen-2-yl)-vinyl]-phenol 
• 199850-51-6 4-chloro-2-[2-(5-chlorothiophen-2-yl)-acetylamino]-5-iodo-benzoic acid methyl ester 
• 850615-87-1 (5-chlorothien-2-yl)(1-hydroxycyclohexyl)acetic acid 
• 1586791-44-7 3-[2-(5-chloro-thiophen-2-yl)-acetylamino]-4-(1-ethyl-propylamino)-benzoic acid methyl ester 
• 1001271-18-6 (R)-4-benzyl-3-(2-(5-chlorothiophen-2-yl)acetyl)oxazolidin-2-one 

Relevant articles and documents

PYRIDINOPYRIDINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

The present invention relates to pyridopyridone derivatives of formula (I): in which the variables are as defined herein, to their preparation and to their therapeutic use as inhibitors of the kinase activity of PDGF (platelet-derived growth factor) ligand receptors and possibly of FLT3 (fms-like tyrosine kinase receptor) ligand receptors.

Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors

A series of heterocyclic cycloalkanol ethylamines have been prepared to expand our norepinephrine reuptake inhibitor (NRI) program. Synthesis of a variety of heterocycles identified (+)-S-21, a potent NRI efficacious in an animal model for thermoregulatory dysfunction.

Substituted oxoazaheterocyclyl compounds

This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..

Quinolones as gonadotropin releasing hormone (GnRH) antagonists: Simultaneous optimization of the C(3)-aryl and C(6)-substituents

A series of 3-arylquinolones was prepared and evaluated for their ability to act as gonadotropin releasing hormone (GnRH) antagonists. A variety of substitution patterns of the 3-aryl substituent are described. The 3,4,5-trimethylphenyl substituent (23h) was found to be optimal. (C) 2000 Elsevier Science Ltd. All rights reserved.